Radiofrequency ablation of a left-sided atrioventricular pathway in a patient with Marfan syndrome

2002 ◽  
Vol 12 (5) ◽  
pp. 494-495 ◽  
Author(s):  
Anji T. Yetman ◽  
Joel Temple ◽  
Christopher C. Erickson
Keyword(s):  
Radiofrequency Ablation ◽  
Marfan Syndrome ◽  
Supraventricular Tachycardia ◽  
Safety And Efficacy

Supraventricular tachycardia is a documented feature of Marfan syndrome. The safety and efficacy of radiofrequency ablation in this population of patients, however, has not been reported. We report on the successful use of radiofrequency ablation utilizing a trans-septal approach for the treatment of supraventricular tachycardia produced by an accessory muscular atrioventricular connection in a patient with Marfan syndrome.

Mo1268 Endoscopic Ultrasound Guided Radiofrequency Ablation (EUS-RFA): Initial Assessment of Safety and Efficacy

2017 ◽  
Vol 85 (5) ◽  
pp. AB484 ◽  
Author(s):  
Tom Malikowski ◽  
Ferga C. Gleeson ◽  
Matthew Block ◽  
Suresh T. Chari ◽  
Barham K. Abu Dayyeh ◽  
...  
Keyword(s):  
Radiofrequency Ablation ◽  
Endoscopic Ultrasound ◽  
Initial Assessment ◽  
Ultrasound Guided ◽  
Safety And Efficacy

Safety and efficacy of percutaneous radiofrequency ablation for hepatocellular carcinoma: a textbook outcome analysis

HPB ◽  
2021 ◽  
Author(s):  
Carla Serra ◽  
Valentina Cossiga ◽  
Matteo Serenari ◽  
Cristina Felicani ◽  
Elena Mazzotta ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Radiofrequency Ablation ◽  
Outcome Analysis ◽  
Percutaneous Radiofrequency Ablation ◽  
Safety And Efficacy

scholarly journals Safety and efficacy of electrophysiological studies and radiofrequency ablation of paroxysmal supraventricular tachycardia

2020 ◽  
Vol 4 (3) ◽  
pp. 818-821
Author(s):  
Abdul Khaliq Monib ◽  
Rajesh Nepal ◽  
Sahadeb Prasad Dhungana ◽  
Roshan Raut
Keyword(s):  
Radiofrequency Ablation ◽  
Electrophysiological Study ◽  
Accessory Pathway ◽  
Study Data ◽  
Female Dominance ◽  
Paroxysmal Supraventricular Tachycardia ◽  
Safety And Efficacy ◽  
Efficacy Analysis ◽  
Early Results ◽  
Reentry Tachycardia

Introduction: Cardiac electrophysiological study (EPS) and radiofrequency ablation (RFA) is an established mode of treatment either as first-line or for drug-refractory arrhythmias. Our center has recently started this service under 2-D mapping outside Kathmandu valley Objective: The aim was to evaluate the safety and efficacy of EPS and RFA for paroxysmal supraventricular tachycardias (PSVT). Methodology: This is an observational prospective study carried out in the Cardiac Unit of Nobel medical college, Biratnagar, Nepal. All cases diagnosed to have PSVT based on electrocardiogram or Holter recordingfromAugust 2018 and May2019wereincluded in the study. Data on clinical profile and findings of EPS were recorded. Fifty-nine cases were chosen for safety and efficacy analysis, using SPSS statistical software version 19. Results: There were 59 patients, 28(47.5%) males, and 31(52.5%) females. The mean age was 38.2 ± 15.9 years. Fifty-three patients underwent RFA while 6 patients underwent only EPS. In the Atrioventricular nodal reentry tachycardia (AVNRT) group, there was female dominance (P=0.2) while in Atrioventricular reentry tachycardia (AVRT) group, there was no significant gender difference (p=0.4). Left-sided pathway (68%) was more common in the AVRT group. Among the left accessory pathway (AP), left lateral AP (44%) was more common. No major complications including death were noted. Two cases of successful ablation relapsed in one month follow up. Conclusions: Early results of this small study in patients with PSVT confirm the efficacy and safety of RFA in newly established electrophysiology (EP) laboratory.

scholarly journals Radiofrequency Ablation, Where It Stands in Interventional Radiology Today

2019 ◽  
Vol 36 (05) ◽  
pp. 398-404
Author(s):  
Vipulkumar Patel ◽  
Charles A. Ritchie ◽  
Carlos Padula ◽  
J. Mark McKinney
Keyword(s):  
Interventional Radiology ◽  
Radiofrequency Ablation ◽  
The Body ◽  
Locoregional Therapy ◽  
Rapid Decline ◽  
Cancer Therapies ◽  
Clinical Use ◽  
Safety And Efficacy ◽  
Body Of Knowledge ◽  
Widespread Acceptance

AbstractRadiofrequency ablation (RFA) is one of the first developed minimally invasive definitive cancer therapies. The safety and efficacy of RFA is well documented and has led to its incorporation into multiple international societal guidelines. By expanding on the body of knowledge acquired during the clinical use of RFA, alternative ablative technologies have emerged and are successfully competing for locoregional therapy market share. The adaption of newer ablative technologies is leading to a rapid decline in the utilization of RFA by interventional radiologists despite the lack of proven superiority. In their 2010 article, Hong and Georgiades stated “… RFA is likely to remain the mainstay of ablations for small tumors until sufficient experience emerges for the widespread acceptance for alternative ablative modalities.” Within a decade of this publication, has this time arrived?

Safety and efficacy of percutaneous radiofrequency ablation for hepatocellular carcinoma patients with haemophilia

Haemophilia ◽  
2020 ◽  
Author(s):  
Takafumi Yamamoto ◽  
Norihiro Imai ◽  
Kenta Yamamoto ◽  
Takanori Ito ◽  
Yoji Ishizu ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Radiofrequency Ablation ◽  
Percutaneous Radiofrequency Ablation ◽  
Safety And Efficacy
Sign in / Sign up

Export Citation Format

Share Document